Search

everythinglearnresearchcommunity

for

Search:↓

A trial showed that a new treatment is safe and effective for male pattern baldness, with most participants growing new hair.

Researchers found a new mutation causing total hair loss from birth.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

NF-κB levels can help diagnose and assess the severity of androgenetic alopecia.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

New method measures skin cell turnover quickly and effectively, showing turnover slows with age and responds more to treatments in older skin.

Menthol boosts the hair growth effects of Phyllanthus niruri gel.

Iontophoresis with a growth factor cocktail helps hair growth in patients with androgenetic alopecia.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

All four treatments for early rheumatoid arthritis had similar safety profiles.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Human adrenals and gonads have a unique enzyme for steroid hormone production.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

This enzyme helps metabolize fatty acids and isoleucine, and could be key in treating neurological diseases and certain cancers.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

3βHSD2 is not useful for diagnosing PCOS.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

A woman's hair loss and other symptoms were due to a rare hormone deficiency treatable with steroids.

A genetic defect causes males in some Mediterranean populations to be born with ambiguous genitalia and develop male traits at puberty.

Increased HSD11B1 enzyme expression is linked to higher body fat and insulin resistance.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Certain hormone levels can help diagnose P450 oxidoreductase deficiency.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

A small group of slow-growing cells causes basal cell carcinoma to return after treatment.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Certain enzymes react strongly with some hormones in rat skin during hair growth, mainly in sebaceous glands and hair sheaths.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.